Takeko Ishikawa

674 total citations
34 papers, 373 citations indexed

About

Takeko Ishikawa is a scholar working on Dermatology, Immunology and Physiology. According to data from OpenAlex, Takeko Ishikawa has authored 34 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Dermatology, 14 papers in Immunology and 11 papers in Physiology. Recurrent topics in Takeko Ishikawa's work include Dermatology and Skin Diseases (19 papers), Asthma and respiratory diseases (11 papers) and Allergic Rhinitis and Sensitization (10 papers). Takeko Ishikawa is often cited by papers focused on Dermatology and Skin Diseases (19 papers), Asthma and respiratory diseases (11 papers) and Allergic Rhinitis and Sensitization (10 papers). Takeko Ishikawa collaborates with scholars based in Japan. Takeko Ishikawa's co-authors include Yayoi Tada, Shinichi Watanabe, Masahiro Kamata, Naoko Kanda, Saki Fukaya, Takamitsu Tanaka, Atsuko Fukuyasu, Kotaro Hayashi, Takamitsu Ohnishi and Shinichi Sato and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical Pharmacology and Journal of the American Academy of Dermatology.

In The Last Decade

Takeko Ishikawa

31 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takeko Ishikawa Japan	11	164	136	73	72	71	34	373
Filamer Kabigting United States	9	171 1.0×	116 0.9×	36 0.5×	36 0.5×	64 0.9×	15	395
S. Karlen Switzerland	7	239 1.5×	312 2.3×	15 0.2×	65 0.9×	146 2.1×	11	500
P.G. van der Valk Netherlands	4	229 1.4×	143 1.1×	67 0.9×	16 0.2×	53 0.7×	6	328
Jana Zeitvogel Germany	11	173 1.1×	148 1.1×	23 0.3×	37 0.5×	58 0.8×	17	317
Momoko Kimishima Japan	10	215 1.3×	180 1.3×	9 0.1×	209 2.9×	88 1.2×	15	529
Carolyn von Allmen United States	11	86 0.5×	185 1.4×	16 0.2×	66 0.9×	172 2.4×	23	385
Alessio Mylonas Switzerland	7	213 1.3×	330 2.4×	12 0.2×	92 1.3×	47 0.7×	8	457
Luisa Senra Switzerland	4	200 1.2×	361 2.7×	6 0.1×	41 0.6×	87 1.2×	5	473
Thomas Ternowitz Denmark	11	87 0.5×	127 0.9×	8 0.1×	124 1.7×	53 0.7×	18	363
Jens Roar Bjerke Norway	10	302 1.8×	303 2.2×	6 0.1×	51 0.7×	58 0.8×	16	549

Countries citing papers authored by Takeko Ishikawa

Since Specialization

Citations

This map shows the geographic impact of Takeko Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeko Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeko Ishikawa more than expected).

Fields of papers citing papers by Takeko Ishikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeko Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeko Ishikawa. The network helps show where Takeko Ishikawa may publish in the future.

Co-authorship network of co-authors of Takeko Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Takeko Ishikawa. A scholar is included among the top collaborators of Takeko Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeko Ishikawa. Takeko Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kamata, Masahiro, Yoshiki Okada, Makoto Ito, et al.. (2024). Possibility of maintaining remission with topical therapy alone after withdrawal of dupilumab in Japanese patients with atopic dermatitis and their characteristics in the real world. Experimental Dermatology. 33(9). e15175–e15175. 1 indexed citations

Kamata, Masahiro, Yoshiki Okada, Makoto Ito, et al.. (2024). Real‐World Experience of 3‐Year Treatment With Dupilumab: Significant Decrease in Circulating Neutrophils and Eosinophils in Japanese Patients With Atopic Dermatitis. Experimental Dermatology. 33(11). e70010–e70010. 1 indexed citations

Kamata, Masahiro, Makoto Ito, Hideaki Uchida, et al.. (2024). Interleukin‐23 inhibitors decrease Fibrosis‐4 index in psoriasis patients with elevated Fibrosis‐4 index but not interleukin‐17 inhibitors. The Journal of Dermatology. 51(9). 1216–1224. 5 indexed citations

Ito, Makoto, Masahiro Kamata, Takeko Ishikawa, et al.. (2023). Improvements in self‐confidence and satisfaction with self‐injection after introducing self‐injection of dupilumab in patients with atopic dermatitis. SHILAP Revista de lepidopterología. 6(5). 152–158. 1 indexed citations

Kamata, Masahiro, Teruo Shimizu, Makoto Ito, et al.. (2023). Expression of interleukin‐36 receptor antagonist in a patient with generalized pustular psoriasis harboring the p.Pro82Leu variant in the IL36RN gene. The Journal of Dermatology. 50(12). 1608–1613. 2 indexed citations

Uchida, Hideaki, Masahiro Kamata, Mayumi Nagata, et al.. (2022). Impact of the COVID‐19 pandemic on biologic treatment in psoriasis patients: A single‐center retrospective study in Japan. The Journal of Dermatology. 49(6). 624–628. 4 indexed citations

Kamata, Masahiro, Teruo Shimizu, Hideaki Uchida, et al.. (2022). Serum levels of angiogenesis‐related factors in patients with psoriasis. The Journal of Dermatology. 50(2). 222–228. 10 indexed citations

Kamata, Masahiro, Mayumi Nagata, Saki Fukaya, et al.. (2021). Edoxaban prevented adverse effects including pyrexia and elevation of D‐dimer caused by the combination of BRAF and MEK inhibitors in a patient with BRAF‐mutant melanoma. The Journal of Dermatology. 48(5). 707–709. 2 indexed citations

Fukuyasu, Atsuko, Masahiro Kamata, Carren Sy Hau, et al.. (2021). Serum interleukin‐10 level increases in patients with severe signs or symptoms of herpes zoster and predicts the duration of neuralgia. The Journal of Dermatology. 48(4). 511–518. 10 indexed citations

10.

Kamata, Masahiro, Makoto Ito, Hideaki Uchida, et al.. (2020). Higher baseline serum lactate dehydrogenase level is associated with poor effectiveness of dupilumab in the long term in patients with atopic dermatitis. The Journal of Dermatology. 47(9). 1013–1019. 25 indexed citations

11.

Kamata, Masahiro, Teruo Shimizu, Mayumi Nagata, et al.. (2020). Thymus and activation‐regulated chemokine (TARC) in patients with psoriasis: Increased serum TARC levels in patients with generalized pustular psoriasis. The Journal of Dermatology. 47(10). 1149–1156. 16 indexed citations

12.

Ito, Makoto, Masahiro Kamata, Hideaki Uchida, et al.. (2020). Introduction of self-injection increases compliance with dupilumab administration in adult patients with atopic dermatitis: A single-center retrospective study. JAAD International. 1(2). 91–92. 6 indexed citations

13.

Kamata, Masahiro, Teruo Shimizu, Hideaki Uchida, et al.. (2019). Thyroid dysfunction in patients with psoriasis: Higher prevalence of thyroid dysfunction in patients with generalized pustular psoriasis. The Journal of Dermatology. 47(2). 133–139. 12 indexed citations

14.

Shimizu, Teruo, Masahiro Kamata, Carren Sy Hau, et al.. (2019). Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod‐induced murine psoriasiform dermatitis. The Journal of Dermatology. 47(2). 155–162. 8 indexed citations

15.

Kamata, Masahiro, Saki Fukaya, Kotaro Hayashi, et al.. (2018). Gastrointestinal bleeding with severe mucosal involvement in a patient with generalized pustular psoriasis without IL36RN mutation. The Journal of Dermatology. 46(1). 73–75. 5 indexed citations

16.

Kamata, Masahiro, Saki Fukaya, Kotaro Hayashi, et al.. (2018). Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid. The Journal of Dermatology. 45(5). 596–599. 50 indexed citations

17.

Fukaya, Saki, Masahiro Kamata, Kotaro Hayashi, et al.. (2018). Open‐label pilot study to evaluate the effectiveness of topical bimatoprost on rhododendrol‐induced refractory leukoderma. The Journal of Dermatology. 45(11). 1283–1288. 2 indexed citations

18.

Kanda, Naoko, Masahiro Kamata, Yayoi Tada, et al.. (2011). Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production in T cells. Journal of Leukocyte Biology. 89(6). 935–944. 58 indexed citations

19.

Ishikawa, Takeko, Naoko Kanda, Carren Sy Hau, Yayoi Tada, & Shinichi Watanabe. (2009). Histamine induces human β-defensin-3 production in human keratinocytes. Journal of Dermatological Science. 56(2). 121–127. 28 indexed citations

20.

Kanda, Naoko, Takeko Ishikawa, & Shinichi Watanabe. (2009). Prostaglandin D2 induces the production of human β-defensin-3 in human keratinocytes. Biochemical Pharmacology. 79(7). 982–989. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact